AMRX.US Amneal Pharmaceuticals, Inc. Class A Common Stock

Healthcare Pharmaceuticals USA Stocks
21.38 USD
Close of Nov 13, 2026
11.39 22.07
Market cap
USD 7.45B
P/E
53.5x
P/B
14.23x
ROE
28.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is AMRX.US undervalued?

Graham number

The Graham number of Amneal Pharmaceuticals, Inc. Class A Common Stock cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Amneal Pharmaceuticals, Inc. Class A Common Stock fundamental analysis

No fundamental analysis for Amneal Pharmaceuticals, Inc. Class A Common Stock yet.

Amneal Pharmaceuticals, Inc. Class A Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, …

Full company profile